Imbruvica (ibrutinib) supply for hospitals & distributors
Bruton's tyrosine kinase (BTK) inhibitor · Janssen / Pharmacyclics (AbbVie)
Imbruvica (ibrutinib) is a first-in-class oral BTK inhibitor marketed by Janssen and Pharmacyclics/AbbVie. It is taken once daily and is available as capsules and as film-coated tablets in several strengths.
Prescription-only medicine. No prices are published. Supply is to hospitals, distributors, pharmacies and physicians against a valid prescription or purchase order. This page is product information, not medical advice.
Product facts
Strengths and presentation
- 140 mg hard capsules
- 140 mg, 280 mg, 420 mg and 560 mg film-coated tablets (market-dependent)
Approved indications (EMA / FDA label summary)
- Chronic lymphocytic leukaemia / small lymphocytic lymphoma, alone or in combination (including with venetoclax)
- Waldenström's macroglobulinaemia
- Relapsed or refractory mantle cell lymphoma (label-dependent)
- Chronic graft-versus-host disease after failure of systemic therapy (FDA label)
Short label summary only. Approved indications differ by country and line of therapy; the national label in the destination country governs.
Storage and cold chain
- Room-temperature product — store as stated on the carton, in the original pack
- No cold chain required; shipped in tamper-evident, temperature-protected packaging
How we supply
- Original manufacturer packs only — sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
- Batch number and expiry confirmed in writing before dispatch; every pack is traceable to its batch.
- Documents with every consignment: commercial invoice, batch / CoA information from the source, and packing list.
- Tamper-evident, temperature-protected shipping; no cold chain is required for this product.
- Named-patient and special-import support: we prepare the paperwork your hospital or importer needs for the local regulator.
Procurement notes
A 420 mg daily dose can be filled as three 140 mg capsules or one 420 mg tablet — the pack counts differ substantially. Please specify capsule or tablet, strength and treatment duration so the quote matches your formulary.
Who we supply
- Hospital pharmacy and procurement departments
- Licensed pharmaceutical distributors and importers
- Oncology and haematology centres
- Treating physicians arranging named-patient supply
Markets served
United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq. Import into each country follows that country's regulator (for example MOHAP / DoH / DHA, SFDA, MoPH, Kuwait MOH, Oman MOH, NHRA) — we work with the receiving institution's import route.
Frequently asked questions
Do you supply Imbruvica capsules or tablets?
Both can be sourced. 140 mg capsules are widely available; tablet strengths depend on the source market and are confirmed per enquiry.
Can Imbruvica be supplied with Venclyxto?
Yes. For the fixed-duration ibrutinib–venetoclax regimen in CLL both products can be quoted together, each with its own batch documents.
Is the Imbruvica you supply an original manufacturer pack?
Yes. We supply Imbruvica only in the original Janssen / Pharmacyclics (AbbVie) pack, sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
Which documents come with a consignment?
Commercial invoice, batch / CoA information from the source and a packing list, with batch number and expiry for every pack. Additional documents requested by your importer can be prepared.
Do you supply the UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq?
Yes — to hospitals, distributors and licensed centres in these countries, through the import or named-patient route accepted by the destination country's regulator.
How do I get a quote for Imbruvica?
Send a supply inquiry on WhatsApp with strength, quantity, country and institution. We reply with a written quote, availability and expiry; we do not publish prices on the site.
Send a supply inquiry
Tell us the product, strength, quantity, destination country and the receiving institution. We reply with availability, batch/expiry and the documentation set — and a written quote. We do not sell to the public.
Send a supply inquiryOther medicines we supply to the Gulf
- Keytruda (pembrolizumab)
- Opdivo (nivolumab)
- Enhertu (trastuzumab deruxtecan)
- Tagrisso (osimertinib)
- Darzalex (daratumumab)
- Imfinzi (durvalumab)
- Tecentriq (atezolizumab)
- Perjeta (pertuzumab)
- Kadcyla (trastuzumab emtansine)
- Lynparza (olaparib)
- Revlimid (lenalidomide)
- Venclyxto (venetoclax)
- Xtandi (enzalutamide)
- Adcetris (brentuximab vedotin)
Sources
Reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-11-04